Section Arrow
INVA.NASDAQ
- Innoviva
Quotes are at least 15-min delayed:2025/07/21 07:28 EDT
Pre Market
Last
 --
-- (--)
Bid
19
Ask
21.95
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 19.57
-0.31 (-1.56%)
Day High 
20.06 
Prev. Close
19.88 
1-M High
21.9699 
Volume 
898.04K 
Bid
19
Ask
21.95
Day Low
19.35 
Open
20.06 
1-M Low
18.75 
Market Cap 
1.25B 
Currency USD 
P/E 51.56 
%Yield 1.28 
10-SMA 19.39 
20-SMA 19.9 
50-SMA 19.82 
52-W High 22 
52-W Low 16.67 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.95/2.74
Enterprise Value
1.51B
Balance Sheet
Book Value Per Share
10.31
Cash Flow
Cash Flow Yield
0.15
Income Statement
Total Revenue
358.71M
Operating Revenue Per Share
4.63
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
Pre Market 2.04 -0.24 -10.53%
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
Pre Market 12.5 -1.575 -11.19%
NCNANuCana plc0.0477+0.0009+1.92%-- 
Pre Market 0.0479 +0.0002 +0.42%
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
Pre Market 6.225 +0.385 +6.59%
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
Pre Market 6.25 +0.33 +5.57%
Quotes are at least 15-min delayed:2025/07/21 07:28 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.